Ketorolac tromethamine compositions for treating or preventing ocular pain
AssigneeAllergan Sales, Inc.
InventorsChristopher A. Muller, Janet K. Cheetham, Teresa H. Kuan, David F. Power
Life of this patent
Estimating the term…
Abstract
Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
Claims19
A method of treating ocular pain in a patient, wherein the method comprises the administration of an ophthalmic composition comprising about 0.4% w/v ketorolac tromethamine to an eye of the patient;
- and wherein the administration results in little or no burning or stinging in the eye of the patient upon topical instillation of the composition.
A method of enhancing comfort in a patient suffering from ocular pain, wherein the method comprises the administration of an ophthalmic composition comprising about 0.4% w/v ketorolac tromethamine to an eye of the patient;
- and wherein the administration results in little or no burning or stinging in the eye of the patient upon topical instillation of the composition.
Dependencies are inferred from the claim text.